In contrast, sgRNAs targeting Gnb1 showed no positive impact on cell survival in the CRISPR-Cas9 screen (Supplementary Figure 10), which confirmed the results of normal GNB1 expression in human MLL-AML (Supplementary Figure 9). The gene discussed is KMT2A; the disease is acute myeloid leukemia.